J. Safra Sarasin Holding Ag Axsome Therapeutics, Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.52 Trillion
- Q1 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 9,660 shares of AXSM stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,660Holding current value
$1.13 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
376Shares Held
37.2MCall Options Held
1.75MPut Options Held
1.18M-
Rtw Investments, LP New York, NY4.05MShares$472 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$452 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$384 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$171 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$162 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...